Have a personal or library account? Click to login
Should Patients With COVID-19 Receive Post-Discharge Thromboprophylaxis? Short Answers to Frequently Asked Questions Cover

Should Patients With COVID-19 Receive Post-Discharge Thromboprophylaxis? Short Answers to Frequently Asked Questions

Romanian Journal of Cardiology
Volume 32 (2022): Issue 3 (September 2022)
By: Călin Pop and  Marcel Pop  
Open Access
|Nov 2022

Authors

Călin Pop

medicbm@yahoo.com

Dr. Constantin Opriş Emergency Clinical County Hospital, Baia Mare, Romania
Faculty of Medicine, “Vasile Goldis” West University, Arad, Romania

Marcel Pop

Directorate of Scientific International Relations, SEMMELWEIS University Budapest, Budapest, Hungary
DOI: https://doi.org/10.2478/rjc-2022-0026 | Journal eISSN: 2734-6382 | Journal ISSN: 1220-658X
Journal RSS Feed
Language: English
Page range: 138 - 143
Published on: Nov 9, 2022
Published by: Romanian Society of Cardiology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
venous thromboembolism,
COVID-19,
hospital discharge,
anticoagulants,
thromboprophylaxis duration
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Cardiology,
Surgery,
Cardiac surgery,
Pediatrics and juvenile medicine,
Paediatric cardiology

© 2022 Călin Pop, Marcel Pop, published by Romanian Society of Cardiology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 32 (2022): Issue 3 (September 2022)Next article